| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.58 | 0.09 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.43 | 0.002 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.41 | 0.01 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.34 | 0.01 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.32 | 0.07 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.3 | 0.04 |